CD8A and neoplasm: PRDM1 upregulation impaired the CD8+ T cell activation (CD8+GZMB+ T cells) and T cell-mediated tumor cell killing activity (CD8+TNFα+ T cells) in the co-culture, whereas PRDM1 knockout had contrasting effects (Fig. 1g, h).